DENVER, COLO. (MMD Newswire) May 29, 2012 -- Grass Roots Research and Distribution, Inc. (GRRD) recently released a report on Medical Marijuana, Inc. (OTC PK: MJNA), a leading innovator in the cannabis and hemp industry. Medical Marijuana, Inc. operates as a holding Company with a focus on acquiring and developing subsidiaries engaged in the medical cannabis and industrial hemp industries.
"MJNA is the first end-to-end or 'seed to sale' fully vertically integrated company in the space," said Michael Llamas, President of Medical Marijuana, Inc. "This report highlights our control in all aspects of the industry and the rapid growth we've seen while complying with all state and federal laws in the United States."
The 47-page report explores Medical Marijuana, Inc.'s role in the $2.4 billion legal medical marijuana market, which Grassroots expects to grow at a rate of 39 percent annually (compounded rate) over the next four years taking the market to $8.9 billion within the 16 legal states and Washington D.C. They further note that as of now, there are as many as 25 million patients eligible to benefit from medical marijuana under the current state laws.
Highlights of Medical Marijuana, Inc.'s operations noted in the report include:
• PhytoSPHERE Systems, a current subsidiary of MJNA, is using a technology that increases the production efficiency and reduces cost per unit with complete control of the growth environment. PhytoSPHERE Systems was integrated for the production of the first pharma grade medical herbs and high value hemp oil.
• Red Dice Holdings, also a current subsidiary which owns the Dixie brand of products, is focused on creating the highest quality medical marijuana formulated products, specifically edibles and beverages. Dixie brand products are currently in more than 400 retail locations in Colorado alone and expanding rapidly, distinguishing itself in the market for alternative medical marijuana treatments with natural ingredients. Dixie's consumer base represents over nine percent of the U.S. medical cannabis market and it focuses on the development of innovative medically and socially acceptable delivery methods.
• Medical Marijuana, Inc. has seen significant growth in its Wellness Management Services, integrating its soon-to-be-released pharma quality, non-THC products with doctors and hospitals, in preparation for Over the Counter (OTC) sales and increased production.
• Grassroots projects revenues for Medical Marijuana, Inc. of approximately $3.8 million in 2012 and $100.06 million in 2017, noting that margins are likely to expand with the Company increasing its production capacity.
"The medical marijuana field is expected to grow by 39 percent in the next five years and Medical Marijuana, Inc. is best positioned to not only take advantage of that growth, but to also lead it," added Llamas. "We know the tremendous opportunity ahead, which will only be enhanced as more states and countries come on line and as we expand our production and distribution globally." The full report can be viewed here. http://www.medicalmarijuanainc.com/images/Pdf/Grass-Roots.pdf
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.medicalmarijuanainc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)Investor Relations Contact:
Stuart T. Smith